 
|
|
| Partnered Pipeline |
|
The research and development capabilities of NPS have led to the discovery of a number of products that have been out-licensed. The result is a valuable royalty-generating portfolio that includes agreements with Amgen, Kyowa Hakko Kirin, Nycomed, and Ortho-McNeil. |
|